MUTANTE REVERSE TRANSKRIPTASE

Patent europeic · EP3516050 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3516050
Numer da la dumonda
EP17853998
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
22-09-2017
Publitgà
31-07-2019
Concedì
11-08-2021
Stritgà
02-05-2022
Motiv
Taxa annuala betg pajada
Classas IPC
C12N 9/00 (2006.01)
C12Q 1/6844 (2018.01)
C12P 19/34 (2006.01)
C12N 15/09 (2006.01)
C12N 9/12 (2006.01)
Prioritad
US 201662398943 P 23.09.2016
Dumonda PCT
PCT/US2017/052980 22.09.2017
Publicaziun PCT
WO2018/057909 29.03.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-06-2022

    Midada

    Published in Swissreg on 22.06.2022

  2. 02-05-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 02.05.2022

  3. 11-08-2021

    Concedì

    Published in Swissreg on 11.08.2021

Partidas

Possessur

New England BioLabs, Inc.

New England Biolabs, Inc.

240 County Road, Ipswich, MA 01938, US

Inventur

NICHOLS, Nicole

Ipswich MA 01938, US

GUAN, Shengxi

Ipswich MA 01938, US

XU, Yan

Ipswich MA 01938, US

ONG, Jennifer

Ipswich MA 01938, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.